Cephalosporin Drugs Market in Europe is expected to register a CAGR of 2.94% during the forecast period (2019-2025) - KBV Research

Published Date: 31-07-2019

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Europe Cephalosporin Drugs Market, published by KBV research, the Europe Cephalosporin Drugs Market would witness market growth of 2.94% CAGR during the forecast period (2019-2025).

The Germany market dominated the Europe Ear Infection Market by Country in 2018, growing at a CAGR of 2.5 % during the forecast period. The UK market is expected to witness a CAGR of 2.2% during (2019 - 2025). Additionally, The France market is expected to witness a CAGR of 4.5% during (2019 - 2025).

The Branded market dominated the Europe Cephalosporin Drugs Market by Type in 2018, growing at a CAGR of 3 % during the forecast period. The Generic market is expected to witness a CAGR of 2.9% during (2019 - 2025).

The Injections market dominated the Spain Cephalosporin Drugs Market by Route of Administration in 2018, thereby, achieving a market value of $155.8 million by 2025, growing at a CAGR of 3.7 % during the forecast period. The Oral Drugs market is expected to witness a CAGR of 3.8% during (2019 - 2025).

Full Report: https://www.kbvresearch.com/europe-cephalosporin-drugs-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of ABBOTT Laboratories, Teva Pharmaceuticals Industries Ltd., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, Baxter International, Inc., Bristol-Myers Squibb Company and Novartis AG.

Europe Cephalosporin Drugs Market Segmentation

By Generation

  • First-Generation Cephalosporin
  • Second-Generation Cephalosporin
  • Third-Generation Cephalosporin
  • Fourth-Generation Cephalosporin
  • Fifth-Generation Cephalosporin

By Application

  • Respiratory Tract Infection
  • Skin Infection
  • Ear Infection
  • Sexually Transmitted Infection
  • Others

By Route of Administration

  • Injections
  • Oral Drugs

By Type

  • Branded
  • Generic

By Country

  • Germany Cephalosporin Drugs Market
  • UK Cephalosporin Drugs Market
  • France Cephalosporin Drugs Market
  • Russia Cephalosporin Drugs Market
  • Spain Cephalosporin Drugs Market
  • Italy Cephalosporin Drugs Market
  • Rest of Europe Cephalosporin Drugs Market

Companies Profiled

  • ABBOTT Laboratories
  • Teva Pharmaceuticals Industries Ltd.
  • Johnson and Johnson
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • Baxter International, Inc.
  • Novartis AG

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Cephalosporin Drugs Market Related Reports:

Global Market

North America Market

Asia Pacific Market

LAMEA Market

Request For Sample

Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.